H9c2 cells exposed to CIS display increased apoptosis, as evidenced according to the increased percentage of TUNEL-positive cells, upregulated expression of Bax, and downregulated expression of Bcl-2. The gene discussed is BCL2; the disease is in situ carcinoma.